Am J Transplant, Volume 21, Suppl 3 Archives - Page 59 of 139 - ATC Abstracts

2021 American Transplant Congress
Outcomes of Second Kidney Transplant After Return to Dialysis by Induction Type in the United States
S. Riad¹, T. Shaker¹, S. Jackson², R. Kandaswamy³
¹Medicine, University of Minnesota, Minneapolis, MN, ²Complex Care Analytics, M-Health Fairview, Minneapolis, MN, ³Surgery, University of Minnesota, Minneapolis, MN
*Purpose: A failed kidney allograft is the 4th leading indication for kidney transplantation. We examined the association of induction use in 2nd kidney transplant recipients…
2021 American Transplant Congress
Evaluation of Empiric Extended-Release Tacrolimus Dosing in Adult Kidney Transplant Recipients
C. Patel, S. Lee, D. M. Salerno, N. W. Lange, J. Hedvat
Pharmacy, NewYork-Presbyterian Hospital, New York, NY
*Purpose: Envarsus XR® (extended-release [XR] tacrolimus) is the standard of care tacrolimus formulation at our center for de novo maintenance immunosuppression in adult kidney transplant…
2021 American Transplant Congress
Impact of Rituximab Induction Therapy on Donor-specific Anti-HLA Antibodies in Abo-compatible Kidney Transplant Recipients
T. Yagisawa¹, T. Kanzawa¹, K. Unagami², M. Furusawa¹, M. Inui¹, H. Ishida², K. Tanabe¹
¹Department of Urology, Tokyo Women's Medical University, Tokyo, Japan, ²Department of Organ Transplant Medicine, Tokyo Women's Medical University, Tokyo, Japan
*Purpose: Development of de novo donor-specific anti-HLA antibodies (dnDSA) after kidney transplantation remains strongly associated with antibody-mediated rejection (AMR), which leads to poor graft outcome.…
2021 American Transplant Congress
Preempting Misconceptions: An Educational Initiative for Preemptive Kidney Transplant Candidates
T. Menser¹, M. Hobeika², H. Ibrahim², A. Khan¹, B. Cruz², J. Sharp², A. Gaber²
¹Houston Methodist Research Institute, Houston, TX, ²Houston Methodist Hospital, Houston, TX
*Purpose: reemptive living donor kidney transplantation (pLDKT) offers many advantages for patients with advanced chronic kidney disease. However, pLDKT represents less than 1 out of…
2021 American Transplant Congress
Early Recovery After Surgery Protocol in Kidney Transplantation is Associated with Decreased Hospital Stay and Improved Clinical Outcomes
Y. Lin, M. Eltemamy, K. Sasaki, V. Krishnamurthi, D. Goldfarb, A. Wee
Cleveland Clinic, Cleveland, OH
*Purpose: Early recovery after surgery protocols (ERAS) has been adopted in many surgical procedures. In 2018 we introduced transplant ERAS to our institution. It included…
2021 American Transplant Congress
Growing Up During the Pandemic: A New Look for Transitioning to Adult Transplant Care
M. M. Chandran, E. Blanchette, A. Sikora, M. Bisek, E. S. Christofferson, M. Bock
Children's Hospital Colorado, Aurora, CO
*Purpose: Adolescent and young adult (AYA) recipients of solid organ transplants (SOT) are confronted with a unique set of life stressors that may negatively impact…
2021 American Transplant Congress
Kidney Allograft Outcomes in Pediatric Patients Transitioned to Adult Care – A Single Center Study
S. Subramanyam, G. Agarwal, M. Seifert, V. Kumar, G. Towns, K. Wille, S. Ong
University of Alabama at Birmingham, Birmingham, AL
*Purpose: The transition of healthcare for young adults with kidney transplants from pediatric to adult care settings is an area of need, hitherto under-recognized in…
2021 American Transplant Congress
The Clinical Significance of Preformed C1q-binding Donor-specific HLA Antibodies in Kidney Transplantation
S. Lee¹, C. Yang², B. Chung²
¹Seoul National University Hospital, Seoul, Korea, Republic of, ²Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of
*Purpose: Complement activation is one dominant mechanism which cause allograft injury in kidney transplantation (KT). Anti-HLA donor-specific antibodies (DSA) that bind to HLA molecules on…
2021 American Transplant Congress
Risk Factors and Outcome of Transplant Renal Artery Stenosis in Kidney Transplant Recipients – A Nested Case-control Study
D. Choudhary¹, A. Sharma¹, R. Vijayvergiya², G. Kasinadhuni², D. Kenwar¹, S. Singh¹
¹Renal & Pancreas Transplant Surgery, Pgimer Chandigarh, Chandigarh, India, ²Cardiology, Pgimer Chandigarh, Chandigarh, India
*Purpose: Transplant renal artery stenosis (TRAS) is a treatable cause of renal allograft dysfunction. It presents commonly in the early post-transplant period with variable clinical…
2021 American Transplant Congress
Risk Factors for Mortality in Kidney Transplant Patients Infected by Sars-cov-2 in South of Spain
V. Lopez¹, T. Vazquez¹, C. Casas¹, I. Poveda², J. Alonso¹, D. Hernandez¹
¹Nephrology, Nephrology Department, Hospital Regional Universitario de Málaga and University of Málaga, IBIMA, REDinREN (RD16/0009/0006), Málaga, Spain, Málaga, Spain, ²Nephrology, Nephrology Department, Hospital Torrecárdenas, Almería., Málaga, Spain
*Purpose: Covid-19 pandemic has especially affected kidney transplant (KT) recipients, who are more vulnerable than the general population due to their immunosuppressive status and added…